在抗微生物药物耐药时代的败血症管理
Silvano Esposito1, Flora Salzano1, Tiziana Ascione2
1Unit of Infectious Diseases, Department of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
败血症的诊断和治疗因抗生素耐药性而复杂化. 本综述涵盖了败血症流行病学,生物标志物,耐药生物体的快速诊断,以及改善生存的新抗生素.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 败血症是全球主要的死亡原因.
- 抗生素耐药性的增加使得败血症的管理和诊断变得复杂.
- 潜在的条件可以降低传统败血症生物标志物的可靠性.
研究的目的:
- 审查败血症流行病学和诊断生物标志物.
- 探索对多药耐药生物体 (MDROs) 的快速识别方法.
- 评估新的抗生素和治疗败血症的治疗策略.
主要方法:
- 关于败血症流行病学的综合文献综述.
- 对当前和新出现的败血症生物标志物的分析.
- 评估新的微生物诊断技术.
- 评估新的抗生素剂和免疫调节疗法.
主要成果:
- 及时诊断至关重要,特别是在性休克时.
- 对于早期的MDRO检测,需要新的诊断方法.
- 新的抗生素和向疗法显示出改善结果的希望.
结论:
- 早期和准确的败血症诊断对于有效的治疗至关重要.
- 诊断和治疗方面的进步对于对抗败血症和抗生素耐药性至关重要.
- 未来的战略包括快速的MDRO识别和创新的治疗方法.
更多相关视频
07:30Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
09:07Author Spotlight: Accelerating Diagnostic Accuracy with Direct Identification of Gram-Negatives from Blood Culture Bottles
Published on: May 24, 2024
相关概念视频
Acute Pyelonephritis II: Diagnostic Studies and Management
Development of Antibiotic Resistance
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Urine Studies II: Urine Culture and Sensitivity Test
Asepsis
